Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies

Seminars in Immunology

Volumn 27, Issue 2, 2015, Pages 111-118

  Sperandio, Brice ^a   Fischer, Natalie ^a   Sansonetti, Philippe J ^a,b  

^a INSTITUT PASTEUR   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

Antimicrobial peptide; Epithelial cell; Evasion; Gastrointestinal mucosa; Mucin; Pathogen

Indexed keywords

MUCIN; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

CYTOPLASM; DOWN REGULATION; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; INTESTINE MUCOSA; MEMBRANE; MUCUS; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW; ANIMAL; IMMUNOLOGY; METABOLISM; MUCOSAL IMMUNITY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; MUCINS; MUCUS;

EID: 84931561003     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.03.011     Document Type: Review

References (94)

1. Sansonetti P.J. War and peace at mucosal surfaces. Nat. Rev. Immunol. 2004, 4:953-964.
2. Woolhouse M.E.J., Webster J.P., Domingo E., Charlesworth B., Levin B.R. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 2002, 32:569-577.
3. Perez-Vilar J., Hill R.L. The structure and assembly of secreted mucins. J. Biol. Chem. 1999, 274:31751-31754.
4. Jentoft N. Why are proteins O-glycosylated?. Trends Biochem. Sci. 1990, 15:291-294.
5. Kawakubo M., Ito Y., Okimura Y., Kobayashi M., Sakura K., Kasama S., et al. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004, 305:1003-1006.
6. Ramos H.C., Rumbo M., Sirard J.-C. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12:509-517.
7. Celli J.P., Turner B.S., Afdhal N.H., Keates S., Ghiran I., Kelly C.P., et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14321-14326.
8. Hornef M.W., Wick M.J., Rhen M., Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 2002, 3:1033-1040.
9. Stecher B., Hapfelmeier S., Müller C., Kremer M., Stallmach T., Hardt W.-D. Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 2004, 72:4138-4150.
10. Songhet P., Barthel M., Stecher B., Müller A.J., Kremer M., Hansson G.C., et al. Stromal IFN-γR-signaling modulates goblet cell function during Salmonella Typhimurium infection. PLoS ONE 2011, 6:e22459.
11. Tu Q.V., McGuckin M.A., Mendz G.L. Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J. Med. Microbiol. 2008, 57:795-802.
12. Schreiber S., Konradt M., Groll C., Scheid P., Hanauer G., Werling H.-O., et al. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5024-5029.
13. Corfield A.P., Wagner S.A., Clamp J.R., Kriaris M.S., Hoskins L.C. Mucin degradation in the human colon: production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 1992, 60:3971-3978.
14. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
15. Mack D.R., Michail S., Wei S., McDougall L., Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276:G941-G950.
16. Mantle M., Husar S.D. Adhesion of Yersinia enterocolitica to purified rabbit and human intestinal mucin. Infect. Immun. 1993, 61:2340-2346.
17. Slomiany B.L., Liu J., Slomiany A. Platelet-derived growth factor activation of gastric mucosal calcium channels. Biochem. Biophys. Res. Commun. 1992, 186:1496-1502.
18. Silva A.J., Pham K., Benitez J.A. Haemagglutinin/protease expression and mucin gel penetration in El Tor biotype Vibrio cholerae. Microbiology (Reading, Engl.) 2003, 149:1883-1891.
19. Neutra M.R., Mantis N.J., Frey A., Giannasca P.J. The composition and function of M cell apical membranes: implications for microbial pathogenesis. Semin. Immunol. 1999, 11:171-181.
20. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
21. Macpherson A.J., McCoy K.D., Johansen F.-E., Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol. 2008, 1:11-22.
22. Siebers A., Finlay B.B. M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol. 1996, 4:22-29.
23. Vazquez-Torres A., Fang F.C. Cellular routes of invasion by enteropathogens. Curr. Opin. Microbiol. 2000, 3:54-59.
24. Jones B., Pascopella L., Falkow S. Entry of microbes into the host: using M cells to break the mucosal barrier. Curr. Opin. Immunol. 1995, 7:474-478.
25. McGuckin M.A., Lindén S.K., Sutton P., Florin T.H. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 2011, 9:265-278.
26. Guttman J.A., Finlay B.B. Tight junctions as targets of infectious agents. Biochim. Biophys. Acta 2009, 1788:832-841.
27. Goosney D.L., Gruenheid S., Finlay B.B. Gut feelings: enteropathogenic E. coli (EPEC) interactions with the host. Annu. Rev. Cell Dev. Biol. 2000, 16:173-189.
28. Mengaud J., Ohayon H., Gounon P., Mege R.-M., Cossart P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell 1996, 84:923-932.
29. Sakaguchi T., Köhler H., Gu X., McCormick B.A., Reinecker H.-C. Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell. Microbiol. 2002, 4:367-381.
30. Meyerholz D.K., Stabel T.J., Ackermann M.R., Carlson S.A., Jones B.D., Pohlenz J. Early epithelial invasion by Salmonella enterica serovar Typhimurium DT104 in the swine ileum. Vet. Pathol. 2002, 39:712-720.
31. Slomiany B.L., Slomiany A. Disruption in gastric mucin synthesis by Helicobacter pylori lipopolysaccharide involves ERK and p38 mitogen-activated protein kinase participation. Biochem. Biophys. Res. Commun. 2002, 294:220-224.
32. Liau Y.H., Lopez R.A., Slomiany A., Slomiany B.L. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin. Biochem. Biophys. Res. Commun. 1992, 184:1411-1417.
33. Slomiany B.L., Slomiany A. Porphyromonas gingivalis lipopolysaccharide interferes with salivary mucin synthesis through inducible nitric oxide synthase activation by ERK and p38 kinase. Biochem. Biophys. Res. Commun. 2002, 297:1149-1153.
34. Sperandio B., Fischer N., Joncquel Chevalier-Curt M., Rossez Y., Roux P., Robbe Masselot C., et al. Virulent Shigella flexneri affects secretion, expression, and glycosylation of gel-forming mucins in mucus-producing cells. Infect. Immun. 2013, 81:3632-3643.
35. Sahl H.-G., Pag U., Bonness S., Wagner S., Antcheva N., Tossi A. Mammalian defensins: structures and mechanism of antibiotic activity. J. Leukoc. Biol. 2005, 77:466-475.
36. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002, 23:291-296.
37. Bals R., Wilson J.M. Cathelicidins - a family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 2003, 60:711-720.
38. Lai Y., Gallo R.L. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30:131-141.
39. Rosenfeld Y., Papo N., Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 2006, 281:1636-1643.
40. Jin T., Bokarewa M., Foster T., Mitchell J., Higgins J., Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 2004, 172:1169-1176.
41. Frick I.-M., Akesson P., Rasmussen M., Schmidtchen A., Björck L. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 2003, 278:16561-16566.
42. Pence M.A., Rooijakkers S.H.M., Cogen A.L., Cole J.N., Hollands A., Gallo R.L., et al. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J. Innate Immun. 2010, 2:587-595.
43. Schmidtchen A., Frick I.-M., Andersson E., Tapper H., Björck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 2002, 46:157-168.
44. Belas R., Manos J., Suvanasuthi R. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 2004, 72:5159-5167.
45. Gutner M., Chaushu S., Balter D., Bachrach G. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect. Immun. 2009, 77:5558-5563.
46. Tavanti A., Maisetta G., Del Gaudio G., Petruzzelli R., Sanguinetti M., Batoni G., et al. Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates. Peptides 2011, 32:2484-2487.
47. Hritonenko V., Stathopoulos C. Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol. Membr. Biol. 2007, 24:395-406.
48. Haiko J., Suomalainen M., Ojala T., Lähteenmäki K., Korhonen T.K. Invited review: breaking barriers - attack on innate immune defences by omptin surface proteases of enterobacterial pathogens. Innate Immun. 2009, 15:67-80.
49. Guina T., Yi E.C., Wang H., Hackett M., Miller S.I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol. 2000, 182:4077-4086.
50. Galván E.M., Lasaro M.A.S., Schifferli D.M. Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Infect. Immun. 2008, 76:1456-1464.
51. Thomassin J.-L., Brannon J.R., Gibbs B.F., Gruenheid S., Le Moual H. OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37. Infect. Immun. 2012, 80:483-492.
52. Peschel A., Sahl H.-G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4:529-536.
53. Vuong C., Voyich J.M., Fischer E.R., Braughton K.R., Whitney A.R., DeLeo F.R., et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 2004, 6:269-275.
54. Kocianova S., Vuong C., Yao Y., Voyich J.M., Fischer E.R., DeLeo F.R., et al. Key role of poly-gamma-dl-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J. Clin. Invest. 2005, 115:688-694.
55. Herasimenka Y., Benincasa M., Mattiuzzo M., Cescutti P., Gennaro R., Rizzo R. Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 2005, 26:1127-1132.
56. Foschiatti M., Cescutti P., Tossi A., Rizzo R. Inhibition of cathelicidin activity by bacterial exopolysaccharides. Mol. Microbiol. 2009, 72:1137-1146.
57. Kai-Larsen Y., Lüthje P., Chromek M., Peters V., Wang X., Holm A., et al. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 2010, 6:e1001010.
58. Neuhaus F.C., Baddiley J. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 2003, 67:686-723.
59. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 1999, 274:8405-8410.
60. Abachin E., Poyart C., Pellegrini E., Milohanic E., Fiedler F., Berche P., et al. Formation of d-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 2002, 43:1-14.
61. Poyart C., Pellegrini E., Marceau M., Baptista M., Jaubert F., Lamy M.-C., et al. Attenuated virulence of Streptococcus agalactiae deficient in d-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 2003, 49:1615-1625.
62. Kristian S.A., Datta V., Weidenmaier C., Kansal R., Fedtke I., Peschel A., et al. d-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J. Bacteriol. 2005, 187:6719-6725.
63. Banemann A., Deppisch H., Gross R. The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect. Immun. 1998, 66:5607-5612.
64. Ilg K., Endt K., Misselwitz B., Stecher B., Aebi M., Hardt W.-D. O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect. Immun. 2009, 77:2568-2575.
65. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3:710-720.
66. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
67. Weidenmaier C., Peschel A., Kempf V.A.J., Lucindo N., Yeaman M.R., Bayer A.S. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 2005, 73:8033-8038.
68. Peschel A., Jack R.W., Otto M., Collins L.V., Staubitz P., Nicholson G., et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 2001, 193:1067-1076.
69. Weidenmaier C., Kristian S.A., Peschel A. Bacterial resistance to antimicrobial host defenses - an emerging target for novel antiinfective strategies?. Curr. Drug Targets 2003, 4:643-649.
70. Ernst R.K., Guina T., Miller S.I. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 2001, 3:1327-1334.
71. Gunn J.S., Lim K.B., Krueger J., Kim K., Guo L., Hackett M., et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 1998, 27:1171-1182.
72. Lee H., Hsu F-F., Turk J., Groisman E.A. The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 2004, 186:4124-4133.
73. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., et al. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 2003, 71:3730-3739.
74. Harder J., Bartels J., Christophers E., Schroder J.M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001, 276:5707-5713.
75. Guo L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276:250-253.
76. Miller S.I., Pulkkinen W.S., Selsted M.E., Mekalanos J.J. Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect. Immun. 1990, 58:3706-3710.
77. Prost L.R., Daley M.E., Bader M.W., Klevit R.E., Miller S.I. The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis. Mol. Microbiol. 2008, 69:503-519.
78. Bayer A.S., Prasad R., Chandra J., Koul A., Smriti M., Varma A., et al. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun. 2000, 68:3548-3553.
79. Shelton C.L., Raffel F.K., Beatty W.L., Johnson S.M., Mason K.M. Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus. PLoS Pathog. 2011, 7:e1002360.
80. Parra-Lopez C., Baer M.T., Groisman E.A. Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium. EMBO J. 1993, 12:4053-4062.
81. Mason K.M., Munson R.S., Bakaletz L.O. A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect. Immun. 2005, 73:599-608.
82. Mount K.L.B., Townsend C.A., Rinker S.D., Gu X., Fortney K.R., Zwickl B.W., et al. Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans. Infect. Immun. 2010, 78:1176-1184.
83. Eswarappa S.M., Panguluri K.K., Hensel M., Chakravortty D. The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence. Microbiology (Reading, Engl.) 2008, 154:666-678.
84. Shafer W.M., Qu X., Waring A.J., Lehrer R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1829-1833.
85. Rinker S.D., Trombley M.P., Gu X., Fortney K.R., Bauer M.E. Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon. Infect. Immun. 2011, 79:2324-2334.
86. Padilla E., Llobet E., Doménech-Sánchez A., Martínez-Martínez L., Bengoechea J.A., Albertí S. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob. Agents Chemother. 2010, 54:177-183.
87. Rieg S., Huth A., Kalbacher H., Kern W.V. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Int. J. Antimicrob. Agents 2009, 33:174-176.
88. Chakraborty K., Ghosh S., Koley H., Mukhopadhyay A.K., Ramamurthy T., Saha D.R., et al. Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell. Microbiol. 2008, 10:2520-2537.
89. Bauer B., Pang E., Holland C., Kessler M., Bartfeld S., Meyer T.F. The Helicobacter pylori virulence effector CagA abrogates human β-defensin 3 expression via inactivation of EGFR signaling. Cell Host Microbe 2012, 11:576-586.
90. Salzman N.H., Chou M.M., de Jong H., Liu L., Porter E.M., Paterson Y. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect. Immun. 2003, 71:1109-1115.
91. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 2001, 7:180-185.
92. Sperandio B., Regnault B., Guo J., Zhang Z., Stanley S.L., Sansonetti P.J., et al. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J. Exp. Med. 2008, 205:1121-1132.
93. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 2007, 8:47-56.
94. Kim D.W., Lenzen G., Page A.-L., Legrain P., Sansonetti P.J., Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14046-14051.